News

25.07.24 Medannex awarded ‘Transforming Cancer Therapeutics’ grant to accelerate new treatment for bone cancer in children
01.06.24 Medannex unveils First-in-Human study of novel cancer therapy at ASCO 2024
18.03.24 Medannex Strengthens Global Intellectual Property Portfolio for Novel Clinical Asset
01.02.24 Sir Graham Brady MP appointed to the board of Medannex
18.01.24 Nature publication demonstrates anti-cancer effects of MDX-124 in multiple tumour types
20.09.23 FDA Grants US Orphan Drug Designation to Medannex’s First-in-Class Therapy MDX-124
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6